NCT02487602View on ClinicalTrials.gov

A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects

NACompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

OverweightObesity

Interventions

DEVICE

Gelesis100

Gelesis100 capsules

OTHER

Placebo

Sucrose (sugar) capsules

Trial Locations (1)

G4 0SF

Bio-Images Research Ltd, Glasgow

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

BDD Pharma Ltd

INDUSTRY

lead

Gelesis, Inc.

INDUSTRY

NCT02487602 - A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects | Biotech Hunter | Biotech Hunter